Sutro Biopharma Inc.

Research Sutro Biopharma Inc. (S090) on Bullrun: market cap EUR 444.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerS090
• ExchangeF
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 444.09M
• Financial periodQ4 2025
• RevenueEUR 11.65M
• Net income-EUR 46.76M
• Free cash flow-EUR 26.62M

Valuation Snapshot

latest market cap is EUR 444.09M.

About Sutro Biopharma Inc.

Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+.

Frequently asked questions

What is Sutro Biopharma Inc.'s market cap?

Sutro Biopharma Inc.'s market capitalization is EUR 444.09M.

What does Sutro Biopharma Inc. do?

Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+.